New data will be presented about Precise® Molecular Residual Disease (MRD) Test and MyRisk® Hereditary Cancer TestSALT LAKE ...
Presentation Title: The ADELA study: A Double-blind, Placebo-controlled, Randomized Phase 3 Trial of Elacestrant (ELA)+ Everolimus (EVE) Versus ELA + Placebo (PBO) in ER+/HER2-Advanced Breast Cancer ...
Dr. Courtney Morris launches Off the Court in Midland, offering cash-pay, holistic PT that bridges rehab and performance ...
The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, ...
The Texas A&M Animal Welfare Judging Team brought home the national title, showcasing the dedication and expertise of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback